The streak of scientific feats recorded by the 12-year-old Afe Babalola University, Ado-Ekiti (ABUAD), has been taken a notch higher as the National Agency for Food and Drug Administration and Control (NAFDAC) recently gave the institution approval to commence the production of the ABUAD Herbal Virucidine Liquid, with effect from December 16, 2021.
A statement issued yesterday and signed by the Director, Corporate Affairs of the institution stated that ABUAD Herbal Virucidine Liquid is an immune booster and antioxidant for coronavirus and other viral infections, which can also be used as an anti-inflammatory agent.
NAFDAC was said to have conveyed the approval news to ABUAD on December 17, 2021, in a letter with index number 210819, serial number 0000177510 and NAFDAC Listing Number A7-100180L signed by the Director-Generalof NAFDAC, Prof Mojisola C Adeyeye.
In his response to the development, the Founder/ Chancellor of the university, Aare Afe Babalola, SAN, recalled: “The university was founded on three pillars of quality and functional education, research and community service in order to reform education and revive research in Nigerian universities.”
Corroborating, the university’s Director of Research, Prof Opemiposi Omotuyi, pointed out that the research breakthrough on herbal medicine has been made possible by the assemblage of quality and sophisticated equipment and infrastructure in the university.
The Chief Pharmacist, Mrs. Toyin Afolabi, expressed gratitude to stakeholders like the National Universities Commission (NUC), the Medical & Dental Council of Nigeria (MDCN), parents, committed and dedicated teachers and students whose combined efforts made the university what it is today.
With this achievement, the Chief Medical Director of ABUAD Multi-System Hospital, Dr. Kolawole Ogundipe, appealed to industries in Nigeria to reach out and partner with ABUAD in research and investment in products and services, which will enhance the quality of their products and quality of life of humanity.
